Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease ovarian cancer
Symptom C0029896|ent disease
Sentences 9
PubMedID- 24616882 Response rates (rr) of 31–40% have been reported in gbrcam ovarian cancer patients with measureable recurrent disease, and the rr and duration of response to parpi monotherapy has been associated with platinum sensitivity (6, 7).
PubMedID- 22967087 The results of our study indicate that presence of two aberrations in tp53 on 17p and loh on 19q in early stage serous ovarian cancer is associated with recurrent disease.
PubMedID- 21045830 Sebastian et al (2008) retrospectively evaluated the diagnostic utility of ct scanning in 51 ovarian cancer patients with recurrent disease.
PubMedID- 23251472 Thus, standard chemotherapy is largely non-beneficial for intrinsically chemoresistant ovarian cancer patients (with persistent or recurrent disease within 6 months).
PubMedID- 20182637 Since current trials have focused on all ovarian cancer patients with advanced/recurrent disease, there may also be a future role for targeting a specific subset of the patient population based on tumor biomarkers.
PubMedID- 23347343 We have hence extended our phase i trial to include the evaluation of mv-nis as a single agent (108 and 109 tcid50 per dose, 6 cycles) in ovarian cancer patients with recurrent disease .
PubMedID- 22709648 Background: for recurrent disease or primary therapy of advanced ovarian cancer, cytoreductive surgery (crs) followed by adjuvant chemotherapy is a therapeutic option.
PubMedID- 23663277 Unfortunately, clinical response to second-line therapy is usually short-lived, and women with recurrent disease will die of ovarian cancer .
PubMedID- 25552305 We sought to report incidence, risk factors, and survival related to bowel obstruction in 311 ovarian cancer patients with recurrent disease.

Page: 1